Produkty 632-32-6

CAS 632-32-6 występuje w naszej ofercie pod nazwami: Ergostenol/ 98.21% (existing batch purity), α–Ergostenol, Ergostenol, α-Ergostenol, 99.97%. Oferty producentów: TargetMol, GLPBio, Chemat, MedChemExpress. Dostępne opakowania: 1mg, 5mg, 10mg, 25mg, 50mg, 100mg, 200mg, 10 mg.

Ergostenol/ 98.21% (existing batch purity)
TargetMol
  • opakowanie: 1mg, 5mg, 10mg, 25mg
  • Warianty: 7
od 757,88
Zobacz produkt
α–Ergostenol
GLPBio
  • opakowanie: 10mg, 5mg
  • Warianty: 2
od 751,50
Zobacz produkt
Ergostenol
Chemat
  • opakowanie: 1mg, 5mg, 10mg, 25mg
  • Warianty: 6
od 256,40
Zobacz produkt
α-Ergostenol, 99.97%
MedChemExpress
  • opakowanie: 10 mg, 5 mg
  • Warianty: 2
od 649,42
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(3S,5S,9R,10S,13R,17R)-17-[(2R,5S)-5,6-dimethylheptan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol (CAS 632-32-6) to związek chemiczny o wzorze sumarycznym C28H48O i masie molowej 400.7 g/mol. Nazwa systematyczna IUPAC: (3S,5S,9R,10S,13R,17R)-17-[(2R,5S)-5,6-dimethylheptan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol. InChIKey: AWYDNKRGSOPYQB-ZHYOCZQLSA-N.

Dane identyfikacyjne
Wzór sumarycznyC28H48O
Masa molowa400.7 g/mol
Nazwa IUPAC(3S,5S,9R,10S,13R,17R)-17-[(2R,5S)-5,6-dimethylheptan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
InChIKeyAWYDNKRGSOPYQB-ZHYOCZQLSA-N
SMILESC[C@H](CC[C@H](C)C(C)C)[C@H]1CCC2=C3CC[C@H]4C[C@H](CC[C@@]4([C@H]3CC[C@]12C)C)O

Dane obliczone przez PubChem (NCBI)

Synonimy: alpha-Ergostenol, delta8(14)-Ergostenol, alpha-Ergostenol [MI], .alpha.-Ergostenol, .DELTA.8(14)-Ergostenol, (3beta,5alpha)-Ergost-8(14)-en-3-ol, 5alpha-Ergost-8(14)-en-3beta-ol, 5alpha-Ergosta-8(14)-ene-3beta-ol, 5.alpha.-Ergost-8(14)-en-3.beta.-ol, .ALPHA.-ERGOSTENOL [MI]
Izomery (ten sam wzór sumaryczny)
(3S,8S,9S,10R,13R,14S,17R)-17-[(2R,5R)-5,6-dimethylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C28H48O
(3S,4R,8S,9S,10R,13R,14S,17R)-4,10,13-trimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C28H48O
(3S,4S,5S,9R,10S,13R,14R,17R)-4,10,13-trimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C28H48O
(3S,5S,9R,10S,13R,14R,17R)-17-[(2R,5S)-5,6-dimethylheptan-2-yl]-10,13-dimethyl-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C28H48O
(3S,4S,8S,9S,10R,13R,14S,17R)-4,10,13-trimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C28H48O
(3R,4S,5S,9R,10S,13R,14R,17R)-4,10,13-trimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C28H48O
(5S,8R,9S,10S,13R,14S,17R)-17-[(2R,5R)-5,6-dimethylheptan-2-yl]-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one C28H48O
(3S,4S,5S,10S,13R,14R,17R)-4,10,13-trimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,7,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C28H48O
(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6,7,7,7-tetradeuterio-5-methyl-6-(trideuteriomethyl)heptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C28H48O
(3S,8S,9S,10R,13R,14S,17R)-17-[(2S,5S)-5,6-dimethylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C28H48O
(1S,2R,5R,7R,8R,10S,11S,14R,15R)-8-methoxy-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]pentacyclo[8.7.0.02,7.05,7.011,15]heptadecane C28H48O
(3S,8S,9S,10R,13R,14S,17R)-17-[(2R,5S)-5,6-dimethylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C28H48O